International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors, Pharmacological Reviews, vol.66, issue.1, pp.1-79, 2014. ,
DOI : 10.1124/pr.113.007724
The Crown and Stem of the V3 Loop Play Distinct Roles in Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Interactions with the CCR5 Coreceptor, Journal of Virology, vol.76, issue.17, pp.8953-8957, 2002. ,
DOI : 10.1128/JVI.76.17.8953-8957.2002
Structure of a V3-Containing HIV-1 gp120 Core, Science, vol.310, issue.5750, pp.1025-1028, 2005. ,
DOI : 10.1126/science.1118398
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody, Nature, vol.393, pp.648-659, 1998. ,
12:50 influencing gp120?CD4 interactions and fusogenicity, Retrovirology Virology, vol.410, pp.418-428, 2015. ,
HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines, Proceedings of the National Academy of Sciences, vol.110, issue.23, pp.9475-9480, 2013. ,
DOI : 10.1073/pnas.1222205110
URL : https://hal.archives-ouvertes.fr/pasteur-00825629
A Synthetic Heparan Sulfate-Mimetic Peptide Conjugated to a Mini CD4 Displays Very High Anti- HIV-1 Activity Independently of Coreceptor Usage, Chemistry & Biology, vol.19, issue.1, pp.131-139, 2012. ,
DOI : 10.1016/j.chembiol.2011.12.009
URL : https://hal.archives-ouvertes.fr/hal-00664771
Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events, J Virol, vol.73, pp.10346-10358, 1999. ,
Multiple CCR5 Conformations on the Cell Surface Are Used Differentially by Human Immunodeficiency Viruses Resistant or Sensitive to CCR5 Inhibitors, Journal of Virology, vol.85, issue.16, pp.8227-8240, 2011. ,
DOI : 10.1128/JVI.00767-11
CCR5 Conformations Are Dynamic and Modulated by Localization, Trafficking and G Protein Association, PLoS ONE, vol.31, issue.2, p.89056, 2014. ,
DOI : 10.1371/journal.pone.0089056.s004
Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains, Virology, vol.315, issue.1, pp.124-134, 2003. ,
DOI : 10.1016/S0042-6822(03)00521-X
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer, Science, vol.342, issue.6165, pp.1477-1483, 2013. ,
DOI : 10.1126/science.1245625
Isolates from Bacteremia and Nasal Colonization at 10 Intensive Care Units: Multicenter Prospective Study in Korea, Journal of Korean Medical Science, vol.26, issue.5, pp.604-611, 2011. ,
DOI : 10.3346/jkms.2011.26.5.604
Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility, Proceedings of the National Academy of Sciences, vol.107, issue.3, pp.1166-1171, 2010. ,
DOI : 10.1073/pnas.0911004107
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes, Nature Biotechnology, vol.20, issue.11, pp.1151-1154, 2002. ,
DOI : 10.1038/nbt745
The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment, Retrovirology, vol.4, issue.1, p.55, 2007. ,
DOI : 10.1186/1742-4690-4-55
Molecular Recognition of CCR5 by an HIV-1 gp120 V3 Loop, PLoS ONE, vol.43, issue.1387, p.95767, 2014. ,
DOI : 10.1371/journal.pone.0095767.s021
Modeling the allosteric modulation of CCR5 function by Maraviroc, Drug Discovery Today: Technologies, vol.10, issue.2, pp.297-305, 2013. ,
DOI : 10.1016/j.ddtec.2012.07.011
URL : https://hal.archives-ouvertes.fr/pasteur-00743086
Differences in the Fitness of Two Diverse Wild-Type Human Immunodeficiency Virus Type 1 Isolates Are Related to the Efficiency of Cell Binding and Entry, Journal of Virology, vol.79, issue.11, pp.7121-7134, 2005. ,
DOI : 10.1128/JVI.79.11.7121-7134.2005
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics, Proceedings of the National Academy of Sciences, vol.99, issue.25, pp.16249-16254, 2002. ,
DOI : 10.1073/pnas.252469399
Adaptive Mutations in a Human Immunodeficiency Virus Type 1 Envelope Protein with a Truncated V3 Loop Restore Function by Improving Interactions with CD4, Journal of Virology, vol.83, issue.21, pp.11005-11015, 2009. ,
DOI : 10.1128/JVI.01238-09
Kinetic Factors Control Efficiencies of Cell Entry, Efficacies of Entry Inhibitors, and Mechanisms of Adaptation of Human Immunodeficiency Virus, Journal of Virology, vol.79, issue.7, pp.4347-4356, 2005. ,
DOI : 10.1128/JVI.79.7.4347-4356.2005
Multiple Active States and Oligomerization of CCR5 Revealed by Functional Properties of Monoclonal Antibodies, Molecular Biology of the Cell, vol.13, issue.2, pp.723-737, 2002. ,
DOI : 10.1091/mbc.01-03-0129
Use of G-Protein-Coupled and -Uncoupled CCR5 Receptors by CCR5 Inhibitor-Resistant and -Sensitive Human Immunodeficiency Virus Type 1 Variants, Journal of Virology, vol.87, issue.12, pp.6569-6581, 2013. ,
DOI : 10.1128/JVI.00099-13
How the Dynamic Properties and Functional Mechanisms of GPCRs Are Modulated by Their Coupling to the Membrane Environment, Adv Exp Med Biol, vol.796, pp.55-74, 2014. ,
DOI : 10.1007/978-94-007-7423-0_4
HIV Infection of T Cells: Actin-in and Actin-out, Science Signaling, vol.2, issue.66, p.23, 2009. ,
DOI : 10.1126/scisignal.266pe23
Role of Abl Kinase and the Wave2 Signaling Complex in HIV-1 Entry at a Post-Hemifusion Step, PLoS Pathogens, vol.75, issue.6, p.1000956, 2010. ,
DOI : 10.1371/journal.ppat.1000956.s012
Ligand- and mutation-induced conformational selection in the CCR5 chemokine G protein-coupled receptor, Proceedings of the National Academy of Sciences, vol.111, issue.36, p.117, 2007. ,
DOI : 10.1073/pnas.1413216111
Replication-Competent Variants of Human Immunodeficiency Virus Type 2 Lacking the V3 Loop Exhibit Resistance to Chemokine Receptor Antagonists, Journal of Virology, vol.81, issue.18, pp.9956-9966, 2007. ,
DOI : 10.1128/JVI.00385-07
Effects of Partial Deletions within the Human Immunodeficiency Virus Type 1 V3 Loop on Coreceptor Tropism and Sensitivity to Entry Inhibitors, Journal of Virology, vol.82, issue.2, pp.664-673, 2008. ,
DOI : 10.1128/JVI.01793-07
A Quantitative Affinity-Profiling System That Reveals Distinct CD4/CCR5 Usage Patterns among Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus Strains, Journal of Virology, vol.83, issue.21, pp.11016-11026, 2009. ,
DOI : 10.1128/JVI.01242-09
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibi? tion (I50) of an enzymatic reaction, Biochem Pharmacol, vol.22, pp.3099-3108, 1973. ,
Mutation of the DRY Motif Reveals Different Structural Requirements for the CC Chemokine Receptor 5-Mediated Signaling and Receptor Endocytosis, Molecular Pharmacology, vol.67, issue.6, pp.1966-1976, 2005. ,
DOI : 10.1124/mol.104.009779
Targeting Spare CC Chemokine Receptor 5 (CCR5) as a Principle to Inhibit HIV-1 Entry, Journal of Biological Chemistry, vol.289, issue.27, pp.19042-19052, 2014. ,
DOI : 10.1074/jbc.M114.559831
URL : https://hal.archives-ouvertes.fr/pasteur-01027514
A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations, Journal of Computational Chemistry, vol.44, issue.16, pp.1999-2012, 2003. ,
DOI : 10.1002/jcc.10349
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists, Science, vol.330, issue.6007, pp.1066-1071, 2010. ,
DOI : 10.1126/science.1194396